These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22010922)

  • 1. Stalking influenza diversity with a universal antibody.
    Russell CJ
    N Engl J Med; 2011 Oct; 365(16):1541-2. PubMed ID: 22010922
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemistry. Catching a moving target.
    Wang TT; Palese P
    Science; 2011 Aug; 333(6044):834-5. PubMed ID: 21836007
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 4. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines.
    Settembre EC; Dormitzer PR; Rappuoli R
    J Mol Cell Biol; 2011 Jun; 3(3):144-6. PubMed ID: 21430014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal influenza vaccine: the holy grail?
    Shaw AR
    Expert Rev Vaccines; 2012 Aug; 11(8):923-7. PubMed ID: 23002973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.
    Corti D; Voss J; Gamblin SJ; Codoni G; Macagno A; Jarrossay D; Vachieri SG; Pinna D; Minola A; Vanzetta F; Silacci C; Fernandez-Rodriguez BM; Agatic G; Bianchi S; Giacchetto-Sasselli I; Calder L; Sallusto F; Collins P; Haire LF; Temperton N; Langedijk JP; Skehel JJ; Lanzavecchia A
    Science; 2011 Aug; 333(6044):850-6. PubMed ID: 21798894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention: Vaccine for all seasons.
    Schlütter J
    Nature; 2011 Nov; 480(7376):S6-8. PubMed ID: 22158298
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospecting the influenza hemagglutinin to develop universal vaccines.
    Donis RO; Cox NJ
    Clin Infect Dis; 2011 Apr; 52(8):1010-2. PubMed ID: 21460315
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protective antigen of influenza virus].
    Nobusawa E
    Nihon Rinsho; 1997 Oct; 55(10):2719-24. PubMed ID: 9360397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One step closer to universal influenza epitopes.
    Li OT; Poon LL
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):687-90. PubMed ID: 19681695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stringing Together a Universal Influenza Antibody.
    Cerulli RA; Kritzer JA
    Biochemistry; 2019 Apr; 58(15):1943-1944. PubMed ID: 30946571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunology. Prime, boost, and broaden.
    Doms RW
    Science; 2010 Aug; 329(5995):1021-2. PubMed ID: 20798304
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress in the Development of Universal Influenza Vaccines.
    Sun W; Luo T; Liu W; Li J
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32957468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steps toward a universal flu vaccine.
    Harrington M
    Lab Anim (NY); 2011 Aug; 40(9):263. PubMed ID: 21857636
    [No Abstract]   [Full Text] [Related]  

  • 18. New Vaccine Design and Delivery Technologies.
    Kanekiyo M; Ellis D; King NP
    J Infect Dis; 2019 Apr; 219(Suppl_1):S88-S96. PubMed ID: 30715361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope.
    Lipatov AS; Gitelman AK; Smirnov YuA
    Acta Virol; 1996 Sep; 40(4):227-30. PubMed ID: 9014015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
    Pertmer TM; Robinson HL
    Virology; 1999 May; 257(2):406-14. PubMed ID: 10329551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.